Ab Science is a pharmaceutical company that specializes in the research, discovery, development and marketing of protein kinase inhibitors.Read more
Founder & CEO
AB Science's revenue is the ranked 23th among it's top 10 competitors. The top 10 competitors average 5.6B. Over the last four quarters, AB Science's revenue has decreased by 0%. Specifically, in Q4 2018's revenue was $1.9M; in Q3 2018, it was $1.9M; in Q2 2018, it was $1.9M; in Q1 2018, AB Science's revenue was $1.9M.